Cas:74420-07-8 3-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide manufacturer & supplier

Chemical Name:3-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide

CAS.NO:74420-07-8

Synonyms:1H-Pyrrolo[2,3-b]pyridine, 3-nitro-, 7-oxide;1H-PYRROLO[2,3-B]PYRIDINE,3-NITRO-,7-OXIDE;3-nitro-1H-pyrrolo[2,3-b]pyridine-7-oxyde;3-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide;3-Nitro-7-oxide-7-azaindole

Molecular Formula:C₇H₅N₃O₃

Molecular Weight:179.133

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:463.3±48.0 °C at 760 mmHg

Density:1.7±0.1 g/cm3

Index of Refraction:1.748

PSA:87.07000

Exact Mass:179.033096

LogP:-0.81

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-Pyrrolo[2,3-b]pyridine, 3-nitro-, 7-oxide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Nitro-7-oxide-7-azaindole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-nitro-1H-pyrrolo[2,3-b]pyridine-7-oxyde Use and application,3-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide technical grade,usp/ep/jp grade.

Related News: The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment. 3-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide manufacturer The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment. 3-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide supplier Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday. 3-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide vendor Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. 3-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide factory Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.